FDA moves toward ruling over menthol cigarettes

Share with others:

Print Email Read Later

WASHINGTON -- Moving closer to a decision on whether to ban menthol in cigarettes, the Food and Drug Administration on Tuesday released a scientific review that found the mint flavoring made it easier to start smoking and harder to quit, and solicited public comment on "potential regulation" of those products.

These steps pleased smoking opponents who have been calling for FDA action ever since 2009, when Congress exempted menthol from a ban on flavors in cigarettes unless the agency decided its use was a danger to public health. Menthol cigarettes account for about a third of all cigarettes sold in the United States and are particularly popular among African-American smokers, about 4 out of 5 of whom report smoking them, according to federal surveys.

Still, the action was only an intermediate step in what advocates say has been a prolonged regulatory process and comes at a time when menthol smoking rates for young adults have been increasing. Many had expected the agency to act on menthol in 2011 after a congressionally mandated committee of outside experts, convened by the FDA, found that menthol had a negative effect on public health. The FDA's findings Tuesday echoed those conclusions, leaving smoking opponents frustrated that the agency had not clearly signaled an intent to ban menthol.

"This is either a way to take the heat off or the beginning of a meaningful process," said Matthew L. Myers, president of the Campaign for Tobacco-Free Kids, an advocacy group. "That's the book the jury is still out on."

Mitchell Zeller, new head of the FDA's Center for Tobacco Products, said the steps the agency took Tuesday showed that it is moving forward as fast as it can, but he emphasized that they did not foreshadow a ban. The public comment period will be open for 60 days.

"The FDA is a regulatory agency," he said in a conference call with journalists. "As a regulatory agency we can only go as far as the regulatory science will take us. The bottom line is, we need more information. We also need input from the public."

Lorillard Inc., the biggest U.S. manufacturer of menthol cigarettes, said in a statement that "the best available science demonstrates that menthol cigarettes have the same health effects as nonmenthol cigarettes and should be treated no differently."

Indeed, the FDA's review found that menthol cigarettes did not increase the risk of disease compared with smoking cigarettes not flavored with menthol.

But the agency did find that the mint flavoring made people more likely to start smoking, and led to greater dependence on nicotine and decreased rates of quitting, conclusions that smoking foes say should spur the agency to action.

Menthol flavoring makes an otherwise-harsh cigarette more palatable for young people who are first-time smokers, and so hooks more of them, anti-smoking advocates say. They say young blacks are particularly vulnerable. More than three-quarters of black adolescent and young adult smokers use Newports, a menthol cigarette produced by Lorillard, according to a 2004 study.

And while smoking rates have been declining across the nation, rates for menthol cigarettes among 18-to-25-year-olds have climbed to 16 percent in 2010, from 13 percent in 2004, according to a 2011 federal report.

The report also found that from 2007 to 2010, 52 percent of new smokers (those who smoked their first cigarette in the year before the survey) smoked menthol cigarettes, compared with 42 percent in the period from 2004 to 2006.

Among smokers 12 and over, 31 percent who had smoked in the past month reported smoking menthols in 2004, 34 percent in 2008 and 38 percent in 2010, the Campaign for Tobacco-Free Kids said, citing federal data.

Mr. Myers said the FDA announcement's timing was likely linked to an international trade dispute.

The United States has until today to comply with a World Trade Organization ruling. It held that the U.S. ban on clove cigarettes under the 2009 law violated Indonesia's trade rights if the United States continued to allow sales of menthol-flavored cigarettes. Indonesia, a maker of clove cigarettes, brought the suit.

The United States contended that menthol posed a different public health risk than other flavors, but the WTO did not accept that.

nation - health


You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here